Serum hepatocyte growth factor as a prog
Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients
β
Yuji Toiyama; Chikao Miki; Yasuhiro Inoue; Yoshinaga Okugawa; Kouji Tanaka; Masa
π
Article
π
2009
π
John Wiley and Sons
π
French
β 205 KB
## Abstract We previously reported that a combination of serum hepatocyte growth factor (HGF) and carcinoembryonic antigen (CEA) was useful for selecting earlyβstage colorectal cancer patients with aggressive disease. The aim of the present study was to determine whether serum HGF could provide CEA